AG009ID7

1365267-27-1 | X-376

Chemical structure of X-376, CAS 1365267-27-1
AG009ID7
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 1365267-27-1
Catalog Number AG009ID7
Chemical Name X-376
IUPAC Name 6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-(4-methylpiperazine-1-carbonyl)phenyl]pyridazine-3-carboxamide
InChI InChI=1S/C25H25Cl2FN6O3/c1-14(21-17(26)7-8-18(28)22(21)27)37-20-13-19(31-32-23(20)29)24(35)30-16-5-3-15(4-6-16)25(36)34-11-9-33(2)10-12-34/h3-8,13-14H,9-12H2,1-2H3,(H2,29,32)(H,30,35)/t14-/m1/s1
InChI Key ONPGOSVDVDPBCY-CQSZACIVSA-N
MDL Number MFCD25976868
Molecular Formula C25H25Cl2FN6O3
Molecular Weight 547.4088
SMILES O([C@H](C)c1c(Cl)c(F)ccc1Cl)c1cc(C(=O)Nc2ccc(cc2)C(=O)N2CCN(CC2)C)nnc1N
UNII 7DR7JMB8BH
Synonyms
6-amino-5-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide, ensartinib, X-396, X-396, 1365267-27-1, X-376, UNII-7DR7JMB8BH, 7DR7JMB8BH, CHEMBL2376648, (R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide, GTPL8959, SCHEMBL15131466, BCP07190, EX-A2227, BDBM50432894, ZINC96258164, AKOS030528612, CS-6077, DB13104, Example 18 [WO2012048259], 3-Pyridazinecarboxamide, 6-amino-5-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-((4-methyl-1-piperazinyl)carbonyl)phenyl)-, BC600712, HY-16590, X376, X 396, X-376; X-396, 6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-(4-methylpiperazine-1-carbonyl)phenyl]pyridazine-3-carboxamide, ensartinib, ALK inhibitors (cancer), D0L9PA, ALK inhibitors (cancer), Xcovery, X396, X-276, X-353, Anaplastic lymphoma kinase inhibitors (cancer), Xcovery, N/A,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited